STEAP3
Metalloreductase STEAP3
Also known as: dudlin-2, STEA3_HUMAN, STMP3, TSAP6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q658P3
- Gene
- STEAP3
- Ensembl
- ENSG00000115107
- Chromosome
- 2
- Canonical length
- 488 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoli,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a multipass membrane protein that functions as an iron transporter. The encoded protein can reduce both iron (Fe3+) and copper (Cu2+) cations. This protein may mediate downstream responses to p53, including promoting apoptosis. Deficiency in this gene can cause anemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
Canonical amino-acid sequenceUniProt
488 residues, UniProt reviewed canonical sequence.
>Q658P3|STEAP3
1 MPEEMDKPLI SLHLVDSDSS LAKVPDEAPK VGILGSGDFA RSLATRLVGS GFKVVVGSRN
61 PKRTARLFPS AAQVTFQEEA VSSPEVIFVA VFREHYSSLC SLSDQLAGKI LVDVSNPTEQ
121 EHLQHRESNA EYLASLFPTC TVVKAFNVIS AWTLQAGPRD GNRQVPICGD QPEAKRAVSE
181 MALAMGFMPV DMGSLASAWE VEAMPLRLLP AWKVPTLLAL GLFVCFYAYN FVRDVLQPYV
241 QESQNKFFKL PVSVVNTTLP CVAYVLLSLV YLPGVLAAAL QLRRGTKYQR FPDWLDHWLQ
301 HRKQIGLLSF FCAALHALYS FCLPLRRAHR YDLVNLAVKQ VLANKSHLWV EEEVWRMEIY
361 LSLGVLALGT LSLLAVTSLP SIANSLNWRE FSFVQSSLGF VALVLSTLHT LTYGWTRAFE
421 ESRYKFYLPP TFTLTLLVPC VVILAKALFL LPCISRRLAR IRRGWEREST IKFTLPTDHA
481 LAEKTSHVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STEAP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 180 nTPM
Expression across tissuesHPA
Tissue
- liver: 180 nTPM
- parathyroid gland: 74 nTPM
- salivary gland: 32 nTPM
- skeletal muscle: 28 nTPM
- pancreas: 27 nTPM
- stomach: 22 nTPM
Single-cell type
- hepatocytes: 101 nCPM
- respiratory ciliated cells: 70 nCPM
- conjunctival goblet cells: 61 nCPM
- breast lactating cells: 48 nCPM
- cytotrophoblasts: 46 nCPM
- thymic myoid cells: 45 nCPM
Immune cell
- myeloid DC: 4.1 nTPM
- intermediate monocyte: 2.7 nTPM
- classical monocyte: 2.4 nTPM
- NK-cell: 1.3 nTPM
- total PBMC: 1 nTPM
- eosinophil: 0.4 nTPM
Brain region
- medulla oblongata: 29 nTPM
- pons: 25 nTPM
- white matter: 24 nTPM
- choroid plexus: 21 nTPM
- midbrain: 19 nTPM
- hypothalamus: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about STEAP3.
Disease | AllUniProt
Conditions STEAP3 is implicated in, by any mechanism.
- Anemia, hypochromic microcytic, with iron overload 2 (AHMIO2) MIM:615234
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.34
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.22
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- cupric reductase (NADH) activity
- FAD binding
- ferric-chelate reductase (NADPH) activity
- heme binding
- identical protein binding
- metal ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STEAP3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STEAP3 as an antibody target. Whether an autoantibody or antibody against STEAP3 could matter depends on whether native STEAP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STEAP3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label STEAP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...